ARS Pharmaceuticals, Inc. SPRY Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from ARS Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s net margin?
- ARS Pharmaceuticals, Inc. (SPRY) reported net margin of -200% in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s net margin changed year-over-year?
- ARS Pharmaceuticals, Inc.'s net margin decreased by 1141.2% year-over-year, from -16.1% to -200%.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s net margin?
- Over 3 years (2022 to 2025), ARS Pharmaceuticals, Inc.'s net margin has grown at a -57.4% compound annual growth rate (CAGR), from -2,635.4% to -203.3%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.